A paper, made visible
A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
Abstract evidence4 comparisonsAutomated source matching · not expert reviewed
This visual is not yet available
- Available sources do not yet support a numeric visual.
No supported comparison is available to draw
- The paper record remains available. Quantitative pictures appear only when their design, measures and sources are established.